Financial Data and Key Metrics Changes - The company generated net investment income (NII) of $0.27 per share, consistent with the previous quarter but down from $0.38 per share in the same quarter last year [26] - The net asset value (NAV) decreased to $7.57 per share from $8.43 at the end of the previous quarter and $9.64 a year ago, primarily due to fair value adjustments and distributions [27] - Investment income for the first quarter was $25 million, slightly down from $26 million in the prior year period, attributed to lower interest and fee income [24] Business Line Data and Key Metrics Changes - The portfolio at the end of the first quarter stood at $690 million, with new debt investments totaling $100 million and equity investments of $2 million [11] - The debt portfolio yield was 15% for the quarter, compared to 15.6% in the same quarter last year, while onboarding yields were 13%, up from 12.6% in the previous quarter [24][12] - The company funded nine debt investments during the quarter, with a significant portion directed towards life science and technology sectors [11] Market Data and Key Metrics Changes - Approximately $92 billion was invested in VC-backed companies in the first quarter, marking a 19% increase from the previous quarter, driven largely by large AI deals [17] - The exit market for VC-backed tech and life science companies remains nearly shut due to tariff-related uncertainties, impacting investor sentiment [18] - The S&P Biotech Select Industry Index is down 14% year over year, reflecting cooling investor sentiment in the life sciences market [18] Company Strategy and Development Direction - The company aims to grow its portfolio while maintaining a focus on high-quality investments, particularly in the tech and life science sectors [10] - The management remains selective in originating loans due to the current macroeconomic environment, with a commitment to optimizing returns from stressed investments [15] - The partnership with Monroe Capital is expected to enhance capital access and operational support, aiding in portfolio growth [9] Management's Comments on Operating Environment and Future Outlook - The management expressed guarded optimism for 2025, despite macroeconomic headwinds impacting recovery from stressed assets [6] - The company anticipates that the venture debt market will remain active, providing opportunities for investment despite current challenges [10] - Management highlighted the importance of maintaining strong liquidity and a robust balance sheet to navigate the current environment [23] Other Important Information - The company declared regular monthly distributions of $0.11 per share through September 2025, supported by undistributed spillover income of $1 per share [7][26] - The company has a committed backlog of $236 million, providing a solid base for future portfolio growth [8] Q&A Session Summary Question: How is the company managing spillover earnings in the current uncertain environment? - The company plans to continue growing distributions through 2025 and will manage spillover earnings quarterly, with confidence in covering distributions over time [32][34] Question: What is the quality of deals currently being pursued? - The company is seeing a higher bar for transaction selection, focusing on companies with strong operational performance and quality VC backing [36][37] Question: Will the company raise leverage ratios to grow the portfolio? - The target leverage ratio is around 1.2x to 1.3x, with the current ratio at 1.29x, indicating a cautious approach to leverage [41] Question: Is there any discussion about cutting the base management fee? - The company’s base management fee is competitive with industry standards, and it is reviewed regularly [43] Question: How does the company plan to address the frozen market conditions? - The company is focusing on generating yield through higher returns from existing portfolio companies rather than relying on warrant expectations [55][52] Question: What is the impact of tariffs on the portfolio? - The primary impact of tariffs is the uncertainty they create, affecting market transactions rather than direct exposure to specific tariffs [63] Question: Has the partnership with Monroe Capital provided additional resources? - The partnership is expected to enhance operational support and focus on stabilizing and growing the business [66]

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”) (Nasdaq: SSSS) today announced that it will report its financial results for the quarter ended March 31, 2025 after the close of the U.S. market on Tuesday, May 6, 2025. Management will hold a conference call and webcast for investors at 2:00 p.m. PT (5:00 p.m. ET). The conference call access number for U.S. participants is 866-580-3963, and the conference call access number for participants outside the U.S. is +1 786-697-3501. ...

Core Insights - SuRo Capital's portfolio has shown resilience despite volatile market conditions, highlighted by CoreWeave's IPO being the largest tech IPO since 2021 and OpenAI's record $40 billion financing at a $300 billion valuation [2][3] - The estimated net asset value of SuRo Capital is projected to be between $6.50 to $7.00 per share as of March 31, 2025 [4] Investment Portfolio Update - As of March 31, 2025, SuRo Capital held positions in 37 portfolio companies, including 32 privately held and 5 publicly held [5] - Recent investments include a $5 million investment in Plaid and a $1 million follow-on investment in WHOOP, alongside smaller investments in Orchard Technologies [3][5] - Liquid assets amounted to approximately $18.1 million, consisting of cash and securities of publicly traded portfolio companies [5] Financial Performance - SuRo Capital's net assets were approximately $157.6 million at the end of 2024, increasing to about $181.7 million by March 31, 2025 [4] - The company has repurchased a total of 1,413,294 of its 6.00% Notes due 2026, utilizing the full authorized funds of $35.3 million under its Note Repurchase Program [12] Share Repurchase Program - Since the inception of the Share Repurchase Program in August 2017, SuRo Capital has repurchased over 6 million shares for approximately $39.3 million, with an additional $25 million available for future repurchases [14]

Investor Presentation F i s c a l Ye a r E n d e d D e c e m b e r 3 1 , 202 4 M a r c h 5 , 2 025 w w w. t p v g . c o m Forward Looking Statements Some of the statements in this presentation constitute forward-looking statements, which relate to future events or our future performance or financial condition. The forward-looking statements contained in this presentation involve risks and uncertainties, including statements as to: our future operating results; our business prospects and the prospects of our ...

之前接过需要编辑文案的广，我的文案总是通不过甲方要求。甲方改好后的文案，在我看来是在侮辱我读者的智商。 所以索性就接这种一键转了。是这个公众号的第一条广，请各位粉丝爸爸理解和原谅。我不会经常接。 然后也希望大家理解，这个号写到至今，再写新内容其实已经比较占用我的精力了，但是我仍然在坚持尽量规律的更新。比如我目前 在准备明年1月发布的内容。 昨天带着有些拧巴的心情发了一篇。相信大家猜得到，那是一篇广。 一篇不需要我做软植入，复制转发即可的广。 最后，为了表达我的歉意，我花了两周的时间写了一篇新的内容。 不一定很干货，但是我真真切切花了两周，因为这个广是两周前，12月2日开始沟通的。当时我就决定要做点什么来表达一下我的歉 意和态度。 为了今天这篇内容，这两周我做了很多的查询，还找同行朋友做了交叉核实。 付出了两周的时间，我才觉得对得起自己接这个广，还得上让读者看广告的歉意。 在我眼中， 2004 年可以看作我国创投行业的开端。 2004 年 6 月，硅谷组织了包括红杉、凯雷、红点、经纬创投、 NEA 、 KPCB 、 DCM 等 25 家美国知名风投团队前来中国考察。 2005 年，以红杉中国的成立为代表，中国的 ...